Background: Thrombocytopenia can be seen in any patients irrespective of age and the causes are diverse.
INTRODUCTION
Megakaryocytes are the largest hematopoietic cells in the bone marrow with size ranging from 40 to 100 um. Nucleus is large with multiple contiguous lobes and cytoplasm is pinkish blue with numerous reddish blue granules. 1 Megakaryocytes (MK) are derived from haematopoietic stem cells (HSCs). These stem cells are located in the marrow sinusoids and depending upon the signals they are capable of producing all types of blood cells. Thrombopoietin is the primary signal for megakaryocyte production. 2 The hallmarks of MK maturation are endo-reduplication (polyploidisation) and expansion of cytoplasmic mass. The megakaryocytes require an intricate series of remodeling events for the production of platelets. Thousands of platelets are released from a single megakaryocyte. 3 Any abnormalities in this process results in clinically significant disorders and inappropriate platelet production is one among them. 4 Thrombocytopenia is defined as platelet counts less than 150,000/µl. A normal human platelet count ranges from 150,000 to 450,000 platelets per microliter of blood. Usually thrombocytopenia has no symptoms and is found on a routine full blood count. When the platelet counts are less than 30, 000/µl, patient suffers from spontaneous bruising and purpura or with continuous/relatively long-lasting bleeding from injuries and wounds. Until the platelet count is less than 10, 000/µl, clinically significant spontaneous bleeding does not usually occur. Thrombocytopenia is a very common condition for which bone marrow aspiration is done. 5 Thrombocytopenia may be due to one of three reasons: a) Decreased production of platelets b) Increased destruction of platelets and c) Changing of distribution of platelets. 6 Thrombocytopenia may be a presenting feature in various hematological disorders like acute myeloid leukemia, chronic lymphocytic leukemia, aplastic anemia, myelodysplastic syndrome, multiple myeloma. Immune thrombocytopenic purpura (ITP), megaloblastic anemia, aplastic anemia and leukemia are common causes of thrombocytopenia. 5 Bone marrow examination helps to differentiate cases of decreased platelet production from cases of peripheral platelet destruction. It also helps to differentiate the number, size and maturity of the megakaryocytes. The ultimate aim of bone marrow examination is to achieve a definite diagnosis with reasonable accuracy using a minimally invasive technique. In addition to microscopic evaluation of the cells and structure, additional tests may be performed, depending on the purpose for testing like immunohistochemistry, flow cytometry and cytogenetic studies. The procedure's low complication rate is an additional advantage that allows bone marrow aspiration to be performed as an outpatient procedure. It is also a suitable procedure when patients are debilitated or having multiple lesions.
Various megakaryocytic alterations in bone marrow aspirates is known as dysmegakaryocytopoiesis and it includes both dysplastic and non-dysplastic features. Dysplastic features are multiple separated nuclei, micromegakaryocytes and hypogranular forms. Non dysplastic features are immature forms, emperipolesis, budding (blebbing of cytoplasm on their surface), cytoplasmic vacuolization and bare nuclei. 3 In myelodysplastic syndrome, dysplastic changes in megakaryocytes are seen along with thrombocytopenia. However, it can also be seen in non-myelodysplastic hematological conditions, as shown by various studies. 7 The present study was undertaken to calculate the prevalence of various conditions associated with thrombocytopenia and to assess megakaryocytic alterations in various cases of thrombocytopenia. Dysplastic megakaryocytic alterations and their contribution to thrombocytopenia were also studied in non-MDS diseases so as to increase the diagnostic accuracy.
MATERIALS AND METHODS
This was a prospective study which included 132 patients, who underwent bone marrow aspiration from 14 th April, 2017 to 13 th April, 2018 in the department of Pathology, Tribhuvan University Teaching Hospital, Institute of Medicine, Maharajgunj, Kathmandu. All the bone marrow samples with thrombocytopenia which were diagnosed on hematology analyzer and confirmed by peripheral smears during the period of one year were taken for the study. Informed consent was taken from the subjects and ethical approval was taken from the Institutional Review Board.
Bone marrow aspiration was performed under aseptic conditions from iliac crest using Salah needle. All universal precautions were taken into consideration. The skin over the site was cleaned with betadine and 2% lidocaine was infiltrated into the skin, subcutaneous tissue and periosteum. About 0.3 ml of marrow was aspirated using 10 ml sterile needle. Smears were made immediately, air dried and stained with Wright stain. Megakaryocyte morphology was studied with a 100X objective. The number of the megakaryocytes was considered as normal: one megakaryocyte per one to three low-power fields, increased: more than two megakaryocytes per low-power field or decreased: one megakaryocyte per five to ten low-power fields. 4 The morphological changes of megakaryocytes that were studied included nuclear segmentation, presence of immature forms, micromegakaryocytes, emperipolesis, cytoplasmic vacuolization, cytoplasmic budding, bare megakaryocytic nuclei and hypogranular forms. The number and morphology of the megakaryocytes in MDS as well as non-MDS related thrombocytopenia were assessed and compared. Statistical analysis like mean, median and descriptive analysis was performed using SPSS version 24.
RESULTS
Of the 516 case of bone marrow aspiration reported in department of pathology from 14 th April, 2017 to 13 th April, 2018, 183 cases had thrombocytopenia. Fifty one cases were excluded from the study, as 42 cases had diluted smears and 9 cases had no megakaryocytes. A total of 132 cases (25.5%) were included in the present study.
The age of the patients who presented with thrombocytopenia ranged from 2 years to 85 years old and most subjects were above 61 years accounting for 27 cases (20.5%).
Thrombocytopenia was more common in males DOI : 10.3126/jpn.v9i2.25408 DOI : 10.3126/jpn.v9i2.25408 accounting for 75 cases (57%) than in females 57 cases (43%). Among the 132 bone marrow aspirate samples, megakaryocytic thrombocytopenia was the most common cause of thrombocytopenia which was observed in 68 cases (51.51%), followed by acute leukemia in 16 cases (12.1%).
There was an increase in the number of megakaryocytes in 33 cases (48.5 %) of megakaryocytic thrombocytopenia (fig 1) and 3 cases (23%) of megaloblastic anemia. 11 cases (68.7%) of acute leukemia and 3 cases (30%) of MDS had decrease in number of megakaryocytes.
As shown in table 2, the most common dysplastic changes observed in the megakaryocytes were micro megakaryocytes (fig 2) , which were observed in 14 cases (20.58%) of megakaryocytic thrombocytopenia followed by in 7 cases of MDS (70%) and 3 cases (23.07%) of megaloblastic anemia. Multiple separate nuclei (fig 3) were most commonly observed in 4 cases (30.76%) of megaloblastic anemia followed by in 2 cases (2.9%) of megakaryocytic DOI : 10.3126/jpn.v9i2.25408 6 ) was observed in one case of megakaryocytopenic thrombocytopenia and one case of megaloblastic anemia. The non dysplastic morphology observed has been tabulated in table 3 .
Megakaryocytic alteration in thrombocytopenia

DISCUSSION
Thrombocytopenia is the most common hematological disorder for which bone marrow aspiration is done. It may be an isolated finding or associated with pancytopenia. 8 It is commonly seen in various hematological disorders including myelodysplastic syndromes (MDS) as well as various non-myelodysplastic hematological conditions. 9 Dysplastic changes are well known in megakaryocytes in thrombocytopenia associated with MDS. However, they are also observed in megakaryocytes in non-myelodysplastic hematological conditions.
In the present study, the youngest patient was 2 years old and the oldest was 85 years old. The most common age group involved was 61 years and above accounting for 27 cases (20.5%). In contrast, thrombocytopenia was seen more commonly in below 20 years (57.9%) in a study conducted by Pokharel S. et al. 8 It was observed that thrombocytopenia was slightly more common in males (56.8%) than in females (43.2%) which was in accordance to that in the similar study conducted by Muhury M et al (male: 63.2% and female: 36.8%) and Gupta P et al (male:58% and female:42%). 3, 9 In this study, the commonest cause of thrombocytopenia for which bone marrow examination was done was megakaryocytic thrombocytopenia seen in 68 cases (51.51%). This was followed by acute leukemia seen in 16 cases ( Out of 68 cases of megakaryocytic thrombocytopenia, 33 cases (48.5%) had increased number of megakaryocytes in bone marrow aspiration smears. The maximum number of megakaryocyte observed was 140/10 LPF. In contrast, Pokharel S et al found increase in the number of megakaryocytes in 15 cases (88.3%) of megakaryocytic thrombocytopenia. 8 The most common dysplastic change observed in megakaryocytic thrombocytopenia was micro megakaryocyte seen in 14 cases (20.58%) followed by multiple separate nuclei in 2 cases (2.9%). The most common non dysplastic changes were immature forms seen in 26 cases (38.2%) and bare nuclei in16 cases (23.5%). Study done by Choudhary PK et al showed young, immature megakaryocytes in 94% (31 cases) of ITP cases. 10 In contrast, hypolobulation (52.94%) & hypogranular forms (35.29%) followed by cytoplasmic vacuolization were the most common morphological alterations found by Gupta P et al. 3 Out of 16 cases of leukemia, 11 cases (68.75%) showed decreased number of megakaryocytes. This corresponds to a study done by Vinayakamurthy S. et al where 65% cases showed decrease in number of megakaryocytes. 11 Leukemic cells infiltrating the marrow may lead to decreased production. Chemotherapy, radiotherapy, and immunemediated destruction of megakaryocytes are the other causes which may result in decreased megakaryocytes. 11 Morphology of megakaryocytes was normal in all 16 cases of acute leukemia in our study. In contrast, Vinayakamurthy S. et al found dysplastic changes in which 60 % showed nuclear segmentation, 40% showed micro megakaryocytes, and 10% showed hypogranular forms. Immature forms (45%), hypolobation (40%), bare nuclei (40%), emperipolesis (5%), and budding (10%) were the non-dysplastic features commonly encountered in cases of acute leukemia. 11 Neelima et al also found dysplastic megakaryocytes, most common being micro megakaryocyte and multiple separate nuclei in 50% of cases, similar to study done by Choudhary et al. 7, 10 In the present study, out of 13 cases of megaloblastic anemia, 3 cases (23.1%) had increased megakaryocyte count and 10 cases (76.9%) had normal number of megakaryocytes. In contrast, 61.8% cases of megaloblastic anemia had increased megakaryocytes in a study done by Neelima et al. 7 Hence, this study shows that dysplastic megakaryocytes are found both in MDS as well as non-MDS related thrombocytopenia. The presence of dysplastic changes in megakaryocytes should not lead to diagnosis of MDS and other hematological conditions should be considered in differential diagnosis. Understanding the morphological changes in the bone marrow aspirates helps in the diagnosis of various hematological conditions associated with thrombocytopenia.
CONCLUSIONS
Many similarities in morphological changes of megakaryocytes were observed in various hematological conditions. The diagnostic accuracy for various causes of thrombocytopenia can be increased by understanding the morphological changes in megakaryocytes in bone marrow aspiration smears and correlating the findings with the patient's clinical findings and other hematological parameters. This can further enable proper therapeutic interventions.
Recommendations
This study was done in limited number of cases and with limited time duration. In every cases of thrombocytopenia, morphological findings of megakaryocytes in bone marrow aspiration smears should be correlated with patient's clinical findings and other hematological parameters which further helps in making diagnosis. Further, cytogenetics and molecular studies whenever needed can help in evaluation of patients in regard to prognosis and determination of clonality.
